| COVID-19 |
1 |
1 |
| Acute Respiratory Distress Syndrome |
0 |
0.68 |
| COVID-19 Treatment |
0 |
0.54 |
| Proton Pump Inhibitor |
0 |
0.44 |
| Receptors |
0 |
0.44 |
| Hospital |
0 |
0.33 |
| Ventilator |
0 |
0.33 |
| Acute Kidney Injury |
0 |
0.3 |
| Sepsis |
0 |
0.29 |
| Acute Liver Failure |
0 |
0.25 |
| Mechanical Ventilation |
0 |
0.24 |
| Liver Failure |
0 |
0.23 |
| Grant |
0 |
0.22 |
| Injury |
0 |
0.22 |
| Liver |
0 |
0.22 |
| Abdominal Pain |
0 |
0.19 |
| Renal Failure |
0 |
0.16 |
| Thromboembolism |
0 |
0.16 |
| Gastroesophageal Reflux Disease |
0 |
0.14 |
| Cardiomyopathy |
0 |
0.12 |
| Diarrhea |
0 |
0.12 |
| Erectile Dysfunction |
0 |
0.12 |
| Wound Management |
0 |
0.12 |
| Abdomen |
0 |
0.11 |
| Blood |
0 |
0.11 |
| Gastroenteritis |
0 |
0.11 |
| Gastrointestinal Cancer |
0 |
0.11 |
| Hemorrhage |
0 |
0.11 |
| Hospitalists |
0 |
0.11 |
| Inpatient Care |
0 |
0.11 |
| Intestinal Pseudo-Obstruction |
0 |
0.11 |
| Ischemia |
0 |
0.11 |
| Kidney |
0 |
0.11 |
| Nausea |
0 |
0.11 |
| Pain |
0 |
0.11 |
| Prognosis |
0 |
0.11 |
| Quality of Life |
0 |
0.11 |
| Respiratory Failure |
0 |
0.11 |
| Steroids |
0 |
0.11 |
| Venous Thromboembolism (VTE) |
0 |
0.11 |
| Pain Management |
0 |
0.1 |
| Abdominal Infection |
0 |
0.06 |
| Inflammatory Bowel Disease |
0 |
0.06 |
| Pancreatitis |
0 |
0.06 |